Go to Home
Go to About the Exchange
Go to Browse Innovations Exchange by Subject
QualityTools
Go to Learn & Network
Go to Resources
Go to Submit Your Innovation
Go to AHRQ Funding Opportunities
Go to FAQs
Go to Contact Us
 
< Back
QualityTool Icon QualityTool:

Guideline for Antiemetics in Oncology: Update 2006—American Society of Clinical Oncology Clinical Practice Guideline


square iconDescription

This slide presentation presents the American Society of Clinical Oncology's recommendations from its updated (2006) clinical practice guideline for the use of antiemetics in oncology.

The following topics are addressed in this slide show:

  • Guideline methodology: Systematic review
  • 2006 Guideline categories for antiemetics in oncology
  • Background
  • Emetic risk of antineoplastic agents: emetic risk categories
  • Chemotherapy-induced acute emesis: Classes of antiemetic agents (highest therapeutic index)
  • Chemotherapy-induced acute emesis: Classes of antiemetic agents (lower therapeutic index)
  • Chemotherapy-induced acute emesis: Antiemetic agents (adjunctive drugs)
  • Chemotherapy-induced acute emesis: Antiemetic agents (combinations of antiemetics)
  • 2006 recommendations for specific emetic risk categories: Chemotherapy-induced acute emesis
  • Chemotherapy-induced delayed emesis
  • 2006 recommendations for prevention of delayed emesis
  • Special emetic problems: Anticipatory emesis
  • Special emetic problems: Pediatric oncology patients
  • Special emetic populations: High-dose chemotherapy
  • Special emetic problems: Vomiting and nausea despite recommended prophylaxis
  • Radiation-induced emesis risk factors
  • Antiemetic regimens for the prevention of radiation-induced emesis
  • 2006 update recommendation changes

Links to the Tool:
This tool is available at: http://www.asco.org/ASCO/Downloads/Cancer%20Policy%20and%20Clinical%20Affai rs/Clinical%20Affairs%20(derivative%20products)/Antiemetics%20slides_2.pdf (If you don't have the software to open this PDF, download free Adobe Acrobat Reader® software.)

Developer

American Society of Clinical Oncology

Funding Sources

American Society of Clinical Oncology


QualityTool Topic

Disease/Condition-Related; Guideline-Related


Related Resources

  • Kris MG, Hesketh PJ, Somerfield MR, et al. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol. 2006 Jun 20;24(18):1-16. [110 references] Available at: http://jco.ascopubs.org/cgi/content/full/24/18/2932

Links to National Guideline Clearinghouse or National Quality Measures Clearinghouse:

This tool is derived from the following guideline in the National Guideline Clearinghouse (NGC): American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006:
http://www.guideline.gov/summary/summary.aspx?view_id=1&doc_id=9372

History

  • Release Date: 05/2006
  • Original Summary: 07/2006
Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.
QualityTool Classification
Disease/Clinical Category: spacer Chemotherapy sickness; Nausea and vomiting; Radiation-induced nausea and vomiting
Patient Population: spacer Vulnerable Populations > Children
Stage of Care: spacer Acute care
Patient Care Process: spacer Active Care Processes: Diagnosis and Treatment > Assessment; Medication: ordering, transcription, administration, dispensing
IOM Domains of Quality: spacer Effectiveness
QualityTool Format: spacer Slide Presentation/Video/DVD
QualityTool Topic: spacer Disease/Condition-Related; Guideline-Related
Developer: spacer American Society of Clinical Oncology
Funding Sources: spacer American Society of Clinical Oncology

 

Last updated: April 11, 2008.

 

 spacer
 
 
AHRQ Advancing Excellence in Health Care